Kamin, W; Maydannik, V; Malek, FA et al.
Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitisINTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. Bd. 48. H. 3. 2010 S. 184-191
Kamin, W; Maydannik, VG; Malek, FA et al.
Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitisACTA PAEDIATRICA. Bd. 99. H. 4. 2010 S. 537-543
Gutjahr, P; Eder, S
Embryonale Tumore bei ErwachsenenProf. P. Gutjahr (Hrsg). Pädiatrische Onkologie. 5. Aufl. Aachen: Shaker 2010
Beck, M
Emerging drugs for lysosomal storage diseasesEXPERT OPINION ON EMERGING DRUGS. Bd. 15. H. 3. 2010 S. 495-507
Beetz, R
Enuresis und funktionelle HarninkontinenzPÄDIATRIE UP2DATE. Bd. 4. 2010 S. 335-362
Beetz, R
Enuresis und Harninkontinenz im Kindesalter, TagungsberichtKONTINENZ AKTUELL. Bd. 53. 2010 S. 7-8
Mehta, A; Clarke, JTR; Beck, M et al.
Enzyme replacement therapy for Fabry's disease ReplyLANCET. Bd. 375. H. 9725. 2010 S. 1523-1524
Harmatz, P; Yu, ZF; Giugliani, R et al.
Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfataseJOURNAL OF INHERITED METABOLIC DISEASE. Bd. 33. H. 1. 2010 S. 51-60
Hahn, A; Mengel, E; Reinke, J et al.
Enzyme replacement therapy in Fabry disease - Preventing infusion-related adverse effects and securing acceptance by switching preparationMONATSSCHRIFT KINDERHEILKUNDE. Bd. 158. H. 5. 2010 S. 477-479
Mehta, A; Beck, M; Elliott, P
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data (vol 374, pg 1986, 2009)LANCET. Bd. 375. H. 9710. 2010 S. 200-200